Adults 18 to 69, any sex, with Obesity. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Weight Change (kg)Primary· 3 Months
Weight Change from baseline to 3 months. Two weight measurements were taken using a Medline MDR500PHY Physician Digital Scale equipped with height rod. The two weight measurements were averaged. Weight was measured in kilograms and height taken at the baseline, using these two measures Body Mass Index was calculated.
Group
Value
95% CI
Arm 1: Receiving MOVE! Toward Your Goals
-1.06
± 1.72
Arm 2: Receiving Enhanced Usual Care
0.07
± 2.40
Weight Change (kg)Primary· 6 Months
Change in weight from baseline to 6-months. Two weight measurements were taken using a Medline MDR500PHY Physician Digital Scale equipped with height rod. The two weight measurements were averaged. Weight was measured in kilograms and height taken at the baseline, using these two measures Body Mass Index was calculated.
Group
Value
95% CI
Arm 1: Receiving MOVE! Toward Your Goals
-1.52
± 3.06
Arm 2: Receiving Enhanced Usual Care
0.23
± 3.64
Weight Change (kg)Primary· 12 months
Change in weight from baseline to the 12-months. Two weight measurements were taken using a Medline MDR500PHY Physician Digital Scale equipped with height rod. The two weight measurements were averaged. Weight was measured in kilograms and height taken at the baseline, using these two measures Body Mass Index was calculated.
Group
Value
95% CI
Arm 1: Receiving MOVE! Toward Your Goals
-1.02
± 4.16
Arm 2: Receiving Enhanced Usual Care
0.74
± 4.90
Percent of Patients With Clinically Significant Weight LossPrimary· 3 months
The percentage of patients who achieve 5-10% weight loss at 3- month study visit.
Group
Value
95% CI
Arm 1: Receiving MOVE! Toward Your Goals
1
Arm 2: Receiving Enhanced Usual Care
2
Percent of Patients With 2.5% Weight Loss at 6 Months.Primary· 6 months
Percentage of patients who achieved 2.5% weight loss at 6 months. Weight measured in kg.
Group
Value
95% CI
Arm 1: Receiving MOVE! Toward Your Goals
7
Arm 2: Receiving Enhanced Usual Care
5
Percent of Patients With Clinically Significant Weight LossPrimary· 6 months
The percentage of patients who achieve 5-10% weight loss at 6- month study visit.
Group
Value
95% CI
Arm 1: Receiving MOVE! Toward Your Goals
2
Arm 2: Receiving Enhanced Usual Care
1
Percent of Patients Who Achieved 2.5% Weight LossPrimary· 12 months
Percentage of patients who achieved 2.5% weight loss at 12 months. Weight measured in kg.
Group
Value
95% CI
Arm 1: Receiving MOVE! Toward Your Goals
5
Arm 2: Receiving Enhanced Usual Care
4
Percent of Patients With Clinically Significant Weight LossPrimary· 12 months
The percentage of patients who achieve 5-10% weight loss at 12- month study visit.
Group
Value
95% CI
Arm 1: Receiving MOVE! Toward Your Goals
2
Arm 2: Receiving Enhanced Usual Care
3
Sponsor's own description
Compared to the general public, a higher percentage of Veterans are obese or overweight with a weight-related medical condition. The VA currently offers an effective weight management program called MOVE!, but the majority of eligible patients do not attend. Veterans see their primary care providers (PCPs) very frequently, making it an important place to receive information on weight management. However, PCPs often fail to discuss weight management with patients, so interventions are needed to encourage weight management counseling within the team-based care model used in primary care at the VA. Investigators used focus groups, interviews, and other research methods to develop the MOVE! Toward Your Goals (MTG) intervention. This intervention combines online tools, counseling by a health coach, and the team-based care model to deliver weight management information to patients.
Investigators will conduct a randomized controlled trial of 320 Veteran patients and their providers at two VA sites (Manhattan and Brooklyn campuses, New York Harbor Healthcare System) to study the impact of the 12-month MTG intervention when compared to Enhanced Usual Care. Veterans in the MTG intervention arm will take the MTG tool, receive personalized weight management materials, health coach counseling, and go to their scheduled primary care (PC) visit. After the initial visit, MTG-arm Veterans will receive follow up telephone coaching over 12 months. All Veterans will attend follow-up visits at 3, 6 and 12 months to assess body mass index, diet and physical activity, and goal attainment.
The objectives of this study are to: (a) test the impact of the MTG intervention on weight and behavior changes; (b) identify predictors of weight loss in Veterans who use goal setting techniques; and (c) determine the impact of the MTG intervention on primary care team obesity-related counseling practices and attitudes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT07403604 — Effect of Insulin Lowering on Lipogenesis
· Phase 1
· recruiting
NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee
· Phase 3
· recruiting
NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass
· recruiting
NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart
· Phase 3
· recruiting
NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl
· Phase 1
· recruiting
Other VA Office of Research and Development trials
Trials by the same sponsor.
NCT07456150 — Personalizing Veteran Pain Care: Adapting Coaching Interventions to Support Maintenance of Self-Care
· Phase 1
· not yet recruiting
NCT06746727 — The Development of a Transdiagnostic Intervention to Improve Social Functioning and Intimate Relationships Among Veteran
· NA
· not yet recruiting
NCT07362576 — Perinatal Peer Support for Veterans With Serious Mental Illness
· NA
· not yet recruiting
NCT06766331 — Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans
· NA
· not yet recruiting
NCT07397195 — ACT for Veterans With IBD and Mental Health Challenges
· NA
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by VA Office of Research and Development
Last refreshed: 21 December 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02626819.